These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Inhibition of fatty acid amide hydrolase modulates anxiety-like behavior in PCP-treated rats. Seillier A, Giuffrida A. Pharmacol Biochem Behav; 2011 Jun; 98(4):583-6. PubMed ID: 21421000 [Abstract] [Full Text] [Related]
5. The cannabinoid transporter inhibitor OMDM-2 reduces social interaction: Further evidence for transporter-mediated endocannabinoid release. Seillier A, Giuffrida A. Neuropharmacology; 2018 Mar 01; 130():1-9. PubMed ID: 29169961 [Abstract] [Full Text] [Related]
7. Inhibition of fatty acid amide hydrolase reverses aberrant prefrontal gamma oscillations in the sub-chronic PCP model for schizophrenia. Seillier A. Exp Brain Res; 2024 May 01; 242(5):1149-1160. PubMed ID: 38489023 [Abstract] [Full Text] [Related]
8. THC and endocannabinoids differentially regulate neuronal activity in the prefrontal cortex and hippocampus in the subchronic PCP model of schizophrenia. Aguilar DD, Giuffrida A, Lodge DJ. J Psychopharmacol; 2016 Feb 01; 30(2):169-81. PubMed ID: 26510449 [Abstract] [Full Text] [Related]
9. Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats. Viana TG, Hott SC, Resstel LB, Aguiar DC, Moreira FA. Psychopharmacology (Berl); 2015 May 01; 232(9):1545-53. PubMed ID: 25388290 [Abstract] [Full Text] [Related]
10. Inhibition of fatty-acid amide hydrolyse (FAAH) exerts cognitive improvements in male but not female rats. Hlavacova N, Chmelova M, Danevova V, Csanova A, Jezova D. Endocr Regul; 2015 Jul 01; 49(3):131-6. PubMed ID: 26238495 [Abstract] [Full Text] [Related]
12. Endocannabinoids in amygdala and nucleus accumbens mediate social play reward in adolescent rats. Trezza V, Damsteegt R, Manduca A, Petrosino S, Van Kerkhof LW, Pasterkamp RJ, Zhou Y, Campolongo P, Cuomo V, Di Marzo V, Vanderschuren LJ. J Neurosci; 2012 Oct 24; 32(43):14899-908. PubMed ID: 23100412 [Abstract] [Full Text] [Related]
14. Inhibition of Fatty Acid Amide Hydrolase Improves Depressive-Like Behaviors Independent of Its Peripheral Antinociceptive Effects in a Rat Model of Neuropathic Pain. Jiang HX, Ke BW, Liu J, Ma G, Hai KR, Gong DY, Yang Z, Zhou C. Anesth Analg; 2019 Aug 24; 129(2):587-597. PubMed ID: 29863609 [Abstract] [Full Text] [Related]
15. Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats. Biernacki M, Łuczaj W, Gęgotek A, Toczek M, Bielawska K, Skrzydlewska E. Toxicol Appl Pharmacol; 2016 Jun 15; 301():31-41. PubMed ID: 27086176 [Abstract] [Full Text] [Related]
16. Elevation of endocannabinoid levels in the ventrolateral periaqueductal grey through inhibition of fatty acid amide hydrolase affects descending nociceptive pathways via both cannabinoid receptor type 1 and transient receptor potential vanilloid type-1 receptors. Maione S, Bisogno T, de Novellis V, Palazzo E, Cristino L, Valenti M, Petrosino S, Guglielmotti V, Rossi F, Di Marzo V. J Pharmacol Exp Ther; 2006 Mar 15; 316(3):969-82. PubMed ID: 16284279 [Abstract] [Full Text] [Related]